<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03072836</url>
  </required_header>
  <id_info>
    <org_study_id>2016-A01720-51</org_study_id>
    <nct_id>NCT03072836</nct_id>
  </id_info>
  <brief_title>Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis</brief_title>
  <acronym>FLORACROHN</acronym>
  <official_title>Study of Gut Microbiota in Crohn's Disease Patients Suffering From Spondylarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The FLORACROHN project aims to compare gut microbiota of patients suffering from Crohn's
      disease (CD) associated or not to spondylarthritis (SpA).

      3 groups of patients will be analyzed: patients suffering from CD alone, patients suffering
      from SpA alone, patients suffering from CD and SpA.

      Fecal microbiota will be determined by 16SRNA gene sequencing.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2017</start_date>
  <completion_date type="Anticipated">February 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiota analysis</measure>
    <time_frame>6 months after last patient inclusion</time_frame>
    <description>16SRNA gene sequencing</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Crohn Disease</condition>
  <condition>Spondyloarthritis</condition>
  <arm_group>
    <arm_group_label>CD alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SPA alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CD + SPA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>analysing microbiota</intervention_name>
    <description>16SRNA gene sequencing of feces</description>
    <arm_group_label>CD alone</arm_group_label>
    <arm_group_label>SPA alone</arm_group_label>
    <arm_group_label>CD + SPA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Crohn's disease and axial spondyloarthritis according to the criteria
             below.

               -  Patients with Crohn's disease (CT patients) diagnosed according to clinical,
                  biological, radiological, endoscopic and / or histological criteria for 3 months.
                  With diagnosis of spondyloarthritis exclusion on modified ASAS and / or New York
                  criteria.

               -  Patients with axial spondyloarthritis (SpA patients) diagnosed according to the
                  modified ASAS and / or New York criteria with exclusion diagnosis of Crohn's
                  disease.

          -  Patient with the capacity to give free and informed consent.

        Exclusion Criteria:

        Antecedent of colonic resection

          -  Antibiotic or colonic colonoscopy preparation in the 8 weeks prior to stool collection
             (against temporary indication = collection possible before colic preparation or on the
             first saddle after the start of the colic preparation).

          -  Ostomy at time of collection

          -  BMI&gt; 30

          -  extreme diet

          -  unbalanced diabetes

          -  Patient under guardianship, under curatorship or under safeguard of justice
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent PEYRIN-BIROULET, MD, PHD</last_name>
      <phone>03 83 15 36 61</phone>
      <email>l.peyrin-biroulet@chu-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2017</study_first_posted>
  <last_update_submitted>April 11, 2017</last_update_submitted>
  <last_update_submitted_qc>April 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Pr Laurent PEYRIN BIROULET</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

